Arrowhead Pharmaceuticals, Inc. - Common Stock - fluxo de caixa (NASDAQ:ARWR)

Financials

Fluxo de caixa operacional -95.39 M171.22 M-136.13 M-153.89 M-462.85 M179.55 M -36.31 M Fluxo de caixa de investimento -240.78 M-141.68 M-5.42 M-96.16 M-420.07 M-129.29 M -704.01 M Fluxo de caixa de financiamento 257.95 M11.3 M65.19 M253.05 M870.52 M74.01 M 741.96 M Fluxo de caixa livre -95.39 M171.22 M-136.13 M-153.89 M-462.85 M156.89 M -50.87 M

Arrowhead Pharmaceuticals, Inc. - Common Stock

Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease.

ARWR

Financials

Arrowhead Pharmaceuticals, Inc. - Common Stock

Notícias

Arrowhead apresenta dados do plozasiran sobre comprometimento renal e hepático

These Are The Upcoming Catalysts For Crispr Therapeutics Stock (NASDAQ:CRSP)

Arrowhead Pharmaceuticals, Inc. (ARWR) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Diretor da Arrowhead Lu Hongbo vende US$ 228.333 em ações

Ação da Arrowhead Pharmaceuticals atinge máxima de 52 semanas em US$ 80,50

Arrowhead Pharmaceuticals, Inc. (ARWR) Q2 2026 Earnings Call Transcript

Sarepta's Q1 Earnings & Sales Beat Estimates, '26 Outlook Maintained

Why This Biotech ETF — The IBD Stock Of The Day — Just Reentered Its Buy Zone

JPMorgan inicia cobertura da Arrowhead Pharma com classificação acima da média

CFO da Arrowhead vende US$ 934.285 em ações da empresa

CMO da Arrowhead Pharmaceuticals vende US$ 750.000 em ações

Stocks Fall as Iran Refuses to Attend Peace Talks